The CITA Network contains a wealth of expertise in delivering Immunotherapies and Immunology research based at leading institutions London-wide. See core contacts at our network partners.
University College London: Cancer Institute
Henning Walczak
Professor of Cancer Biology
Lead applicant; contributes to cell death; inflammation; proteomics
h.walczak@ucl.ac.uk
Sergio Quezada
Group Leader: Immune Regulation and Tumour Immunotherapy Lab,
CRUK Senior Cancer Research Fellow
Co-leading scientist IMDC; GEnTILs Immunology and immunotherapy
s.quezada@ucl.ac.uk
Kerry Chester
Professor of Molecular Medicine, Head of the Recombinant Antibody Therapeutics Group
Provision of non-GMP-grade immune‐modulatory biotherapeutics
k.chester@ucl.ac.uk
Javier Herrero
Professorial Research Associate, Head of the Bill Lyons Informatics Centre
Bioinformatics
javier.herrero@ucl.ac.uk
Teresa Marafioti
Consultant Haematopathologist & Honorary Reader
Multi-colour IHC, tumour microenvironment and IHC assay development
t.marafioti@ucl.ac.uk
Karl Peggs
Reader in Haematology
Co-leading clinician scientist: ACT with GEnTILs and CARs
karl.peggs@ucl.ac.uk
Martin Pule
Senior Lecturer in Haematology
CAR-modified T cell therapies
martin.pule@ucl.ac.uk
University College London: Institute of Immunity & Transplantation
Emma Morris
Reader in Immunology and Immunotherapy
TCR-modified T cell therapies
e.morris@ucl.ac.uk
Hans Stauss
Head of Institute of Immunity &Transplantation, Professor of Tumour Immunology
TCR-modified T cell therapies
h.stauss@ucl.ac.uk
Ronjon Chakraverty
Professor of Haematology and Cellular Therapy ACT
Adaptive immune-regulation / Immune-activation
r.chakraverty@ucl.ac.uk
King's College London
Adrian Hayday
Kay Glendinning Professor of Immunobiology
Co-leading scientist IMDC; adaptiveimmune-regulation / Immune-activation
adrian.hayday@kcl.ac.uk
Tony Ng
Professor of Molecular Oncology
Tumour microenvironment/ Imaging
tony.ng@kcl.ac.uk
The Francis Crick Institute
Charles Swanton
Co-Director CRUK Lung Cancer Centre of Excellence
Co-leading clinician scientist: genomics; bioinformatics; GEnTILs
Charles.Swanton@crick.ac.uk
Julian Downward
Head of Signal Transduction Laboratory Response and resistance
iGEMMs
Julian.Downward@crick.ac.uk
Caetano Reis e Sousa
Head of Immuno-biology Laboratory
Adaptive immune-regulation / Immune-activation
Caetano@crick.ac.uk
Gitta Stockinger
Head of Division of Molecular Immunology
Adaptive immune-regulation / Immune-activation
Brigitta.Stockinger@crick.ac.uk
Royal Marsden Hospital
James Larkin
Medical Oncologist
Co-leading clinician scientist: clinical trials
James.Larkin@rmh.nhs.uk
Martin Gore
Medical Director of The Royal Marsden and Professor of Cancer Medicine
Clinical trials
Martin.Gore@rmh.nhs.uk
Institute of Cancer Research
Alan Melcher
Professor of Translational Immunotherapy
Oncolytic Viruses
Alan.Melcher@icr.ac.uk
Barts Cancer Institute
Frances Balkwill
Centre Lead, Centre for Cancer and Inflammation
Inflammation
f.balkwill@qmul.ac.uk
Kairbaan Hodivala-Dilke
Professor of Angiogenesis, Deputy Institute Director
Angiogenesis
k.hodivala-dilke@qmul.ac.uk